AstraZeneca, Singapore's A*STAR To Partner For Hospital-Bug Drug
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca and the Agency for Science, Technology and Research in Singapore have agreed to co-develop treatments for the prevalent form of hospital infections, gram-negative bacteria.